Norovirus cases are significantly increasing in the US and Canada. Moderna is developing an mRNA-based vaccine, currently in ...

Moderna is testing a norovirus vaccine in a phase three trial. Results could be available as soon as this year.

Moderna provided an update on the status of its trial investigating a vaccine candidate for norovirus in a company statement on Monday.

Lehigh Valley’s health networks are seeing abnormally high cases of the stomach bug that’s taking a large number of people ...

“Commonly known as the stomach flu, norovirus has been around forever, and has become the leading cause of gastroenteritis or inflammation of the intestinal tract that causes vomiting and diarrhea,” ...

Norovirus, often erroneously called the "stomach flu," sickens an estimated 21 million Americans and 685 million people worldwide every year, and though there is currently no preventive vaccine, a ...

Moderna conducts phase 3 trial for norovirus vaccine as cases rise in the U.S., with results expected in late 2025 or early 2026.

A stomach illness outbreak at the University of Guelph is part of a trend that has experts noticing a rise in stomach bugs ...

Unless they’re covering me in a cloud of norovirus particles. When the violent expelling of liquid starts somewhere other ...

BRITS are being urged to stay at home and mask up when venturing outside after a “worrying” surge in norovirus cases. While ...

Volunteers in north Wales are among 25,000 people taking part in a global trial to find a vaccine against the symptoms of the ...

Moderna, Inc. (NASDAQ:MRNA) has announced updates demonstrating substantial R&D investment and progress in the UK, two years ...